Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
GO_Biological_Process_2021,Proteoglycans in cancer,6/205,0.0017669673592828,0.1660386881985937,0,0,5.027765948385998,31.868446992721765,WNT2B;ERBB4;ITPR1;PIK3R3;TIMP3;ANK2
GO_Biological_Process_2021,Spinocerebellar ataxia,5/143,0.0019848946995808,0.1660386881985937,0,0,6.009621239800268,37.39300166235887,GRIA2;PSMC6;ITPR1;PIK3R3;MAP3K5
GO_Biological_Process_2021,Protein processing in endoplasmic reticulum,5/171,0.0042824211079396,0.1660386881985937,0,0,4.988863015085553,27.20545113407936,BCAP31;HSPH1;CANX;CALR;MAP3K5
GO_Biological_Process_2021,Glucagon signaling pathway,4/107,0.0044437366849436,0.1660386881985937,0,0,6.399029126213592,34.65880332442269,LDHA;PKM;ITPR1;PRKAG2
GO_Biological_Process_2021,Human papillomavirus infection,7/331,0.0046147647643539,0.1660386881985937,0,0,3.6104252400548695,19.41865187856072,BCAP31;LAMA5;WNT2B;PKM;PIK3R3;LAMC1;PPP2R3A
GO_Biological_Process_2021,Glutamatergic synapse,4/114,0.0055590292452442,0.1660386881985937,0,0,5.989696969696969,31.100493941159797,GRIA2;ITPR1;GRIK1;GRIK2
GO_Biological_Process_2021,PI3K-Akt signaling pathway,7/354,0.0066045068316948,0.1660386881985937,0,0,3.3671519002931105,16.903112673591448,LAMA5;ERBB4;PKN3;DDIT4;PIK3R3;LAMC1;PPP2R3A
GO_Biological_Process_2021,Alzheimer disease,7/369,0.0082086689102278,0.1660386881985937,0,0,3.225149926807385,15.48899054231972,PSMC6;WNT2B;ITPR1;PIK3R3;GAPDH;RTN4;MAP3K5
GO_Biological_Process_2021,Glycolysis / Gluconeogenesis,3/67,0.0083501793444014,0.1660386881985937,0,0,7.675103305785124,36.72899397765495,LDHA;PKM;GAPDH
GO_Biological_Process_2021,FoxO signaling pathway,4/131,0.0090093133311371,0.1660386881985937,0,0,5.183464566929134,24.41150783217295,BCL6;PIK3R3;PRKAG2;KLF2
GO_Biological_Process_2021,Central carbon metabolism in cancer,3/70,0.0094145647947656,0.1660386881985937,0,0,7.330331812014308,34.19964358938645,LDHA;PKM;PIK3R3
GO_Biological_Process_2021,PPAR signaling pathway,3/74,0.0109516590148388,0.1770518207398947,0,0,6.915958561285065,31.220465013243807,SCP2;ACOX1;ANGPTL4
GO_Biological_Process_2021,Biosynthesis of unsaturated fatty acids,2/27,0.0120947557122399,0.1804909698595802,0,0,13.017049180327868,57.47005517001714,SCP2;ACOX1
GO_Biological_Process_2021,Circadian rhythm,2/31,0.015767174190479,0.2184879852109242,0,0,11.219332956472584,46.5582693172924,BHLHE40;PRKAG2
GO_Biological_Process_2021,Propanoate metabolism,2/34,0.0187945087853043,0.2362206406682372,0,0,10.165983606557376,40.40155585559051,LDHA;ACOX1
GO_Biological_Process_2021,Small cell lung cancer,3/92,0.0195838200851954,0.2362206406682372,0,0,5.512210975949484,21.679809975364883,LAMA5;PIK3R3;LAMC1
GO_Biological_Process_2021,Hepatocellular carcinoma,4/168,0.0206997468626805,0.2362206406682372,0,0,4.006504065040651,15.535755613055116,PBRM1;WNT2B;PHF10;PIK3R3
GO_Biological_Process_2021,"Alanine, aspartate and glutamate metabolism",2/37,0.0220453659011322,0.2376000547122034,0,0,9.29320843091335,35.450364141776255,GLUD1;RIMKLB
GO_Biological_Process_2021,Amoebiasis,3/102,0.0256161523135699,0.2615543973069774,0,0,4.952917605810168,18.15012593509918,LAMA5;PIK3R3;LAMC1
GO_Biological_Process_2021,Prion disease,5/273,0.0277095334878935,0.268782474832567,0,0,3.0741251724570424,11.02374756098863,PSMC6;ITPR1;PIK3R3;LAMC1;NCAM2
GO_Biological_Process_2021,HIF-1 signaling pathway,3/109,0.0303667507210087,0.2700198909278185,0,0,4.624200842039607,16.158839770593083,LDHA;PIK3R3;GAPDH
GO_Biological_Process_2021,D-Glutamine and D-glutamate metabolism,1/5,0.0306208123732577,0.2700198909278185,0,0,40.39024390243903,140.8034339839893,GLUD1
GO_Biological_Process_2021,Type II diabetes mellitus,2/46,0.0330487598960871,0.2779066157729526,0,0,7.388971684053652,25.19470310779092,PKM;PIK3R3
GO_Biological_Process_2021,Pyruvate metabolism,2/47,0.0343801998894374,0.2779066157729526,0,0,7.224408014571949,24.34823785570828,LDHA;PKM
GO_Biological_Process_2021,Phosphonate and phosphinate metabolism,1/6,0.0366324477864724,0.2780805559074022,0,0,32.31056910569106,106.84526455648567,CHPT1
GO_Biological_Process_2021,Sphingolipid signaling pathway,3/119,0.037900692752845,0.2780805559074022,0,0,4.223425477343973,13.822367303896396,PIK3R3;PPP2R3A;MAP3K5
GO_Biological_Process_2021,AMPK signaling pathway,3/120,0.038701933038659,0.2780805559074022,0,0,4.187115914388642,13.615938753199549,PIK3R3;PRKAG2;PPP2R3A
GO_Biological_Process_2021,MicroRNAs in cancer,5/310,0.0440091863433405,0.3049207910931451,0,0,2.696101391376222,8.420886846985423,ZEB2;DDIT4;PIK3R3;TIMP3;ZFPM2
GO_Biological_Process_2021,Regulation of lipolysis in adipocytes,2/55,0.0457492344294098,0.3059596147074116,0,0,6.131456851221776,18.912970530321875,PIK3R3;MGLL
GO_Biological_Process_2021,Dopaminergic synapse,3/132,0.0489824023642356,0.3059596147074116,0,0,3.795310397847396,11.447772667356237,GRIA2;ITPR1;PPP2R3A
GO_Biological_Process_2021,Vascular smooth muscle contraction,3/133,0.0498937842220827,0.3059596147074116,0,0,3.7659249841068014,11.289711537036563,ITPR1;KCNMB4;ADM
GO_Biological_Process_2021,Long-term depression,2/60,0.0534587096432134,0.3059596147074116,0,0,5.601469756924816,16.405840641650475,GRIA2;ITPR1
GO_Biological_Process_2021,Apelin signaling pathway,3/137,0.0536217881445979,0.3059596147074116,0,0,3.652769211792278,10.687271422978306,ITPR1;PRKAG2;KLF2
GO_Biological_Process_2021,Autophagy,3/137,0.0536217881445979,0.3059596147074116,0,0,3.652769211792278,10.687271422978306,DDIT4;ITPR1;PIK3R3
GO_Biological_Process_2021,Fluid shear stress and atherosclerosis,3/139,0.0555348308110348,0.3059708764396221,0,0,3.5986874088478364,10.402887176283292,PIK3R3;KLF2;MAP3K5
GO_Biological_Process_2021,Apoptosis,3/142,0.0584649494575951,0.3059708764396221,0,0,3.52048278732386,9.995804854756775,ITPR1;PIK3R3;MAP3K5
GO_Biological_Process_2021,Signaling pathways regulating pluripotency of stem cells,3/143,0.0594576657147191,0.3059708764396221,0,0,3.495159386068477,9.865054933008548,WNT2B;PIK3R3;TBX3
GO_Biological_Process_2021,GnRH secretion,2/64,0.0599324397149775,0.3059708764396221,0,0,5.2390269698572185,14.745437115388128,ITPR1;PIK3R3
GO_Biological_Process_2021,Cell adhesion molecules,3/148,0.0645397108117084,0.3073491811342079,0,0,3.3737817041892275,9.245762975618396,CNTN1;NRCAM;NCAM2
GO_Biological_Process_2021,Retrograde endocannabinoid signaling,3/148,0.0645397108117084,0.3073491811342079,0,0,3.3737817041892275,9.245762975618396,GRIA2;ITPR1;MGLL
GO_Biological_Process_2021,Long-term potentiation,2/67,0.0649552393118687,0.3073491811342079,0,0,4.996469104665826,13.660630692693942,GRIA2;ITPR1
GO_Biological_Process_2021,Phagosome,3/152,0.0687452661551608,0.3173638435644387,0,0,3.2825447889511343,8.788512758481628,CANX;CALR;SEC22B
GO_Biological_Process_2021,mTOR signaling pathway,3/154,0.0708938352099862,0.3173638435644387,0,0,3.238738985277215,8.571555265082988,WNT2B;DDIT4;PIK3R3
GO_Biological_Process_2021,Non-alcoholic fatty liver disease,3/155,0.0719794284372953,0.3173638435644387,0,0,3.2172683775554587,8.465839309761728,PIK3R3;PRKAG2;MAP3K5
GO_Biological_Process_2021,Thyroid hormone synthesis,2/75,0.0789960108347074,0.3405605800429611,0,0,4.4471143049629465,11.28836783294977,CANX;ITPR1
GO_Biological_Process_2021,Antigen processing and presentation,2/78,0.0844852903618623,0.3563075289174197,0,0,4.270923209663503,10.554210784930882,CANX;CALR
GO_Biological_Process_2021,B cell receptor signaling pathway,2/81,0.0900870766139219,0.3717456526554,0,0,4.108113716538701,9.88814163143724,CD81;PIK3R3
GO_Biological_Process_2021,Peroxisome,2/82,0.0919783058116453,0.3717456526554,0,0,4.05655737704918,9.679767501091714,SCP2;ACOX1
GO_Biological_Process_2021,ErbB signaling pathway,2/85,0.0977208692393312,0.3817943878132586,0,0,3.909342287181513,9.091723334014675,ERBB4;PIK3R3
GO_Biological_Process_2021,Nitrogen metabolism,1/17,0.100368627724104,0.3817943878132586,0,0,10.091463414634148,23.19932168971406,GLUD1
GO_Biological_Process_2021,Primary bile acid biosynthesis,1/17,0.100368627724104,0.3817943878132586,0,0,10.091463414634148,23.19932168971406,SCP2
GO_Biological_Process_2021,ECM-receptor interaction,2/88,0.1035623221264743,0.3863671248564621,0,0,3.772398017537171,8.55422071475538,LAMA5;LAMC1
GO_Biological_Process_2021,One carbon pool by folate,1/20,0.1170131002125961,0.3914870999502636,0,0,8.496790757381259,18.22960442221716,MTHFD1L
GO_Biological_Process_2021,Transcriptional misregulation in cancer,3/192,0.1170417702319716,0.3914870999502636,0,0,2.582579037124492,5.540211558570112,BCL6;NFKBIZ;PBX3
GO_Biological_Process_2021,Circadian entrainment,2/97,0.1216254039872709,0.3914870999502636,0,0,3.4134598792062123,7.191509417724148,GRIA2;ITPR1
GO_Biological_Process_2021,Phosphatidylinositol signaling system,2/97,0.1216254039872709,0.3914870999502636,0,0,3.4134598792062123,7.191509417724148,ITPR1;PIK3R3
GO_Biological_Process_2021,Huntington disease,4/306,0.1227654110491522,0.3914870999502636,0,0,2.160485651214128,4.531575383055347,GRIA2;PSMC6;ITPR1;MAP3K5
GO_Biological_Process_2021,Choline metabolism in cancer,2/98,0.1236780892740945,0.3914870999502636,0,0,3.3777322404371586,7.059707440693926,PIK3R3;CHPT1
GO_Biological_Process_2021,Inflammatory mediator regulation of TRP channels,2/98,0.1236780892740945,0.3914870999502636,0,0,3.3777322404371586,7.059707440693926,ITPR1;PIK3R3
GO_Biological_Process_2021,Arginine biosynthesis,1/22,0.1279393433544284,0.3914870999502636,0,0,7.686798296554394,15.805587027633496,GLUD1
GO_Biological_Process_2021,Focal adhesion,3/201,0.1292953872842112,0.3914870999502636,0,0,2.464062108690208,5.040622619841607,LAMA5;PIK3R3;LAMC1
GO_Biological_Process_2021,Epstein-Barr virus infection,3/202,0.1306843765582664,0.3914870999502636,0,0,2.4515552971468915,4.988841978639258,PSMC6;PIK3R3;CALR
GO_Biological_Process_2021,Chagas disease,2/102,0.1319715160260559,0.3914870999502636,0,0,3.241967213114754,6.565532041600689,PIK3R3;CALR
GO_Biological_Process_2021,Longevity regulating pathway,2/102,0.1319715160260559,0.3914870999502636,0,0,3.241967213114754,6.565532041600689,PIK3R3;PRKAG2
GO_Biological_Process_2021,Diabetic cardiomyopathy,3/203,0.1320786817246609,0.3914870999502636,0,0,2.439173553719008,4.937759180450804,PDK4;PIK3R3;GAPDH
GO_Biological_Process_2021,Proximal tubule bicarbonate reclamation,1/23,0.1333520651461152,0.3914870999502636,0,0,7.337028824833703,14.78237084448453,GLUD1
GO_Biological_Process_2021,C-type lectin receptor signaling pathway,2/104,0.1361653477400181,0.3914870999502636,0,0,3.178077788492446,6.336722710319434,ITPR1;PIK3R3
GO_Biological_Process_2021,Vitamin digestion and absorption,1/24,0.1387314605097311,0.3914870999502636,0,0,7.017674089784376,13.86141620257972,SLC52A3
GO_Biological_Process_2021,alpha-Linolenic acid metabolism,1/25,0.1440777329710281,0.3914870999502636,0,0,6.724932249322493,13.02889929294851,ACOX1
GO_Biological_Process_2021,Insulin resistance,2/108,0.1446403278885706,0.3914870999502636,0,0,3.057531704299412,5.911753190797638,PIK3R3;PRKAG2
GO_Biological_Process_2021,Human immunodeficiency virus 1 infection,3/212,0.1448585461057118,0.3914870999502636,0,0,2.333069714104947,4.507484987525028,ITPR1;PIK3R3;CALR
GO_Biological_Process_2021,Lipid and atherosclerosis,3/215,0.1492071174430413,0.3914870999502636,0,0,2.2997037268049274,4.375002107090746,ITPR1;PIK3R3;MAP3K5
GO_Biological_Process_2021,cAMP signaling pathway,3/216,0.1506660619710542,0.3914870999502636,0,0,2.2887905948085208,4.331969700572098,GRIA2;ACOX1;PIK3R3
GO_Biological_Process_2021,TNF signaling pathway,2/112,0.1532228395523365,0.3914870999502636,0,0,2.94575260804769,5.525825230217425,PIK3R3;MAP3K5
GO_Biological_Process_2021,Toxoplasmosis,2/112,0.1532228395523365,0.3914870999502636,0,0,2.94575260804769,5.525825230217425,LAMA5;LAMC1
GO_Biological_Process_2021,Human T-cell leukemia virus 1 infection,3/219,0.1550704713896584,0.3914870999502636,0,0,2.256657483930211,4.206128847264724,CANX;PIK3R3;CALR
GO_Biological_Process_2021,Cholinergic synapse,2/113,0.1553840551348984,0.3914870999502636,0,0,2.9190666075911977,5.434880076992601,ITPR1;PIK3R3
GO_Biological_Process_2021,Neuroactive ligand-receptor interaction,4/341,0.1620525897527567,0.4027316697578687,0,0,1.932640949554896,3.51708642163539,GRIA2;ADM;GRIK1;GRIK2
GO_Biological_Process_2021,Human cytomegalovirus infection,3/225,0.1639989789220187,0.4027316697578687,0,0,2.1949966495421043,3.9683236373150095,ITPR1;PIK3R3;CALR
GO_Biological_Process_2021,"Growth hormone synthesis, secretion and action",2/119,0.1684703117361841,0.4029505137442229,0,0,2.7685301947597027,4.930740472380064,ITPR1;PIK3R3
GO_Biological_Process_2021,Neurotrophin signaling pathway,2/119,0.1684703117361841,0.4029505137442229,0,0,2.7685301947597027,4.930740472380064,PIK3R3;MAP3K5
GO_Biological_Process_2021,beta-Alanine metabolism,1/30,0.1703192893145684,0.4029505137442229,0,0,5.5640594336977856,9.848832720808518,ACOX1
GO_Biological_Process_2021,Pathways of neurodegeneration,5/475,0.1729140410060455,0.4032554413261253,0,0,1.7348471303414983,3.044588500885547,GRIA2;PSMC6;WNT2B;ITPR1;MAP3K5
GO_Biological_Process_2021,Thermogenesis,3/232,0.1746054488216212,0.4032554413261253,0,0,2.1271428055866326,3.712345841734654,PRKAG2;MGLL;MAP3K5
GO_Biological_Process_2021,Platelet activation,2/124,0.1795149289233347,0.4097164260132581,0,0,2.654393980112873,4.55891344555518,ITPR1;PIK3R3
GO_Biological_Process_2021,SNARE interactions in vesicular transport,1/33,0.1856795079436543,0.4188584248961505,0,0,5.041666666666667,8.48882138384114,SEC22B
GO_Biological_Process_2021,Amyotrophic lateral sclerosis,4/364,0.1900684804685783,0.4203347696268752,0,0,1.807037037037037,3.0003516179858685,GRIA2;PSMC6;ERBB4;MAP3K5
GO_Biological_Process_2021,Purine metabolism,2/129,0.190667318181263,0.4203347696268752,0,0,2.549244868981541,4.224672733943997,PNP;PKM
GO_Biological_Process_2021,Nicotinate and nicotinamide metabolism,1/35,0.1957626017989517,0.4267184803258049,0,0,4.744619799139167,7.737775389195103,PNP
GO_Biological_Process_2021,Parkinson disease,3/249,0.2011171818385142,0.4335192586296862,0,0,1.978431767788752,3.1731425054727644,PSMC6;ITPR1;MAP3K5
GO_Biological_Process_2021,Aldosterone-regulated sodium reabsorption,1/37,0.2057218390754153,0.4353397244482906,0,0,4.480578139114725,7.084825997590153,PIK3R3
GO_Biological_Process_2021,Estrogen signaling pathway,2/137,0.208693785431397,0.4353397244482906,0,0,2.3972070431086823,3.756153134348804,ITPR1;PIK3R3
GO_Biological_Process_2021,Insulin signaling pathway,2/137,0.208693785431397,0.4353397244482906,0,0,2.3972070431086823,3.756153134348804,PIK3R3;PRKAG2
GO_Biological_Process_2021,Various types of N-glycan biosynthesis,1/39,0.215558728940831,0.4448765256863959,0,0,4.244330338040222,6.513017780191769,MGAT4A
GO_Biological_Process_2021,Nicotine addiction,1/40,0.2204317601793912,0.4501448576294937,0,0,4.135292891390453,6.25325389907968,GRIA2
GO_Biological_Process_2021,Breast cancer,2/147,0.2314580638662078,0.4672481634751432,0,0,2.230751837196156,3.2643853602829687,WNT2B;PIK3R3
GO_Biological_Process_2021,Fatty acid degradation,1/43,0.2348714120416546,0.4672481634751432,0,0,3.839334107626791,5.562108964344489,ACOX1
GO_Biological_Process_2021,Gastric cancer,2/149,0.2360325774255878,0.4672481634751432,0,0,2.200178432028549,3.17658559336279,WNT2B;PIK3R3
GO_Biological_Process_2021,Glycosphingolipid biosynthesis,1/45,0.2443501333352632,0.4675931145319118,0,0,3.664449371766445,5.163770227170264,B3GNT2
GO_Biological_Process_2021,Oxytocin signaling pathway,2/154,0.247489877782956,0.4675931145319118,0,0,2.1272648835202763,2.970482041493348,ITPR1;PRKAG2
GO_Biological_Process_2021,Proteasome,1/46,0.2490457206952842,0.4675931145319118,0,0,3.582836495031617,4.980568305018746,PSMC6
GO_Biological_Process_2021,Cushing syndrome,2/155,0.2497841322861762,0.4675931145319118,0,0,2.113254044787314,2.931417687435754,WNT2B;ITPR1
GO_Biological_Process_2021,Cellular senescence,2/156,0.2520790886978317,0.4675931145319118,0,0,2.0994251649989355,2.893033903250412,ITPR1;PIK3R3
GO_Biological_Process_2021,Carbohydrate digestion and absorption,1/47,0.2537123636044813,0.4675931145319118,0,0,3.5047720042417816,4.806984343279935,PIK3R3
GO_Biological_Process_2021,Hepatitis C,2/157,0.2543746509756946,0.4675931145319118,0,0,2.0857747223691168,2.85531524674453,CD81;PIK3R3
GO_Biological_Process_2021,Cocaine addiction,1/49,0.2629595230513715,0.4675931145319118,0,0,3.3584010840108403,4.4860015887240845,GRIA2
GO_Biological_Process_2021,Ether lipid metabolism,1/49,0.2629595230513715,0.4675931145319118,0,0,3.3584010840108403,4.4860015887240845,CHPT1
GO_Biological_Process_2021,Cholesterol metabolism,1/50,0.2675403902734135,0.4675931145319118,0,0,3.2896963663514187,4.337414433160371,ANGPTL4
GO_Biological_Process_2021,Cysteine and methionine metabolism,1/50,0.2675403902734135,0.4675931145319118,0,0,3.2896963663514187,4.337414433160371,LDHA
GO_Biological_Process_2021,Malaria,1/50,0.2675403902734135,0.4675931145319118,0,0,3.2896963663514187,4.337414433160371,CD81
GO_Biological_Process_2021,N-Glycan biosynthesis,1/50,0.2675403902734135,0.4675931145319118,0,0,3.2896963663514187,4.337414433160371,MGAT4A
GO_Biological_Process_2021,cGMP-PKG signaling pathway,2/167,0.2773432702164571,0.479784505449702,0,0,1.9583705911574765,2.511608907136813,ITPR1;KCNMB4
GO_Biological_Process_2021,Glycosaminoglycan biosynthesis,1/53,0.2811142242445527,0.479784505449702,0,0,3.099437148217636,3.933167765190728,B3GNT2
GO_Biological_Process_2021,Tight junction,2/169,0.2819352248518867,0.479784505449702,0,0,1.9347207224894476,2.449507214298113,PRKAG2;MAP3K5
GO_Biological_Process_2021,Hedgehog signaling pathway,1/56,0.2944385008409751,0.4924230100271481,0,0,2.9299334811529936,3.5823860798545817,SPOPL
GO_Biological_Process_2021,Pyrimidine metabolism,1/56,0.2944385008409751,0.4924230100271481,0,0,2.9299334811529936,3.5823860798545817,PNP
GO_Biological_Process_2021,Legionellosis,1/57,0.2988252582369337,0.4954880350253431,0,0,2.877468060394889,3.4756830150133777,SEC22B
GO_Biological_Process_2021,Endometrial cancer,1/58,0.3031849599911523,0.4984566291379961,0,0,2.8268435315932106,3.37358964486458,PIK3R3
GO_Biological_Process_2021,VEGF signaling pathway,1/59,0.3075177715810386,0.5013314931657268,0,0,2.777964676198486,3.2758381715988367,PIK3R3
GO_Biological_Process_2021,Glycerolipid metabolism,1/61,0.3161033814216578,0.5110337999650135,0,0,2.6850948509485093,3.0923860478226133,MGLL
GO_Biological_Process_2021,Basal cell carcinoma,1/63,0.3245833918852311,0.5204064299647507,0,0,2.5982166273275635,2.9235465804528133,WNT2B
GO_Biological_Process_2021,Cortisol synthesis and secretion,1/65,0.332959091370805,0.5214162373466836,0,0,2.5167682926829267,2.767779802385325,ITPR1
GO_Biological_Process_2021,Kaposi sarcoma-associated herpesvirus infection,2/193,0.336696600350711,0.5214162373466836,0,0,1.6895545446742768,1.8392035435579328,ITPR1;PIK3R3
GO_Biological_Process_2021,Acute myeloid leukemia,1/67,0.341231752702783,0.5214162373466836,0,0,2.440256220744025,2.623747397118361,PIK3R3
GO_Biological_Process_2021,Fc epsilon RI signaling pathway,1/68,0.3453298375705027,0.5214162373466836,0,0,2.403713141609028,2.5557606599694376,PIK3R3
GO_Biological_Process_2021,Mitophagy,1/68,0.3453298375705027,0.5214162373466836,0,0,2.403713141609028,2.5557606599694376,BNIP3L
GO_Biological_Process_2021,Adipocytokine signaling pathway,1/69,0.3494026332735508,0.5214162373466836,0,0,2.3682448589191774,2.4902813329565507,PRKAG2
GO_Biological_Process_2021,Amphetamine addiction,1/69,0.3494026332735508,0.5214162373466836,0,0,2.3682448589191774,2.4902813329565507,GRIA2
GO_Biological_Process_2021,Renal cell carcinoma,1/69,0.3494026332735508,0.5214162373466836,0,0,2.3682448589191774,2.4902813329565507,PIK3R3
GO_Biological_Process_2021,Renin secretion,1/69,0.3494026332735508,0.5214162373466836,0,0,2.3682448589191774,2.4902813329565507,ITPR1
GO_Biological_Process_2021,Prolactin signaling pathway,1/70,0.3534502945066562,0.5227149723559325,0,0,2.33380464239425,2.4271857979133378,PIK3R3
GO_Biological_Process_2021,Viral carcinogenesis,2/203,0.3591881741088705,0.5227149723559325,0,0,1.6046815104803849,1.643047625615816,PKM;PIK3R3
GO_Biological_Process_2021,Melanoma,1/72,0.361470828307882,0.5227149723559325,0,0,2.2678346501774875,2.307689433181221,PIK3R3
GO_Biological_Process_2021,Non-small cell lung cancer,1/72,0.361470828307882,0.5227149723559325,0,0,2.2678346501774875,2.307689433181221,PIK3R3
GO_Biological_Process_2021,p53 signaling pathway,1/73,0.36544400573697,0.5227149723559325,0,0,2.236224028906956,2.2510774998703584,PPM1D
GO_Biological_Process_2021,Glioma,1/75,0.3733169370716762,0.5227149723559325,0,0,2.1755658097121517,2.143644870153851,PIK3R3
GO_Biological_Process_2021,Rap1 signaling pathway,2/210,0.3747702196916809,0.5227149723559325,0,0,1.550126103404792,1.5213591550774677,PIK3R3;RAPGEF5
GO_Biological_Process_2021,Chronic myeloid leukemia,1/76,0.3772169903599512,0.5227149723559325,0,0,2.146449864498645,2.092648424370323,PIK3R3
GO_Biological_Process_2021,Gastric acid secretion,1/76,0.3772169903599512,0.5227149723559325,0,0,2.146449864498645,2.092648424370323,ITPR1
GO_Biological_Process_2021,Pancreatic cancer,1/76,0.3772169903599512,0.5227149723559325,0,0,2.146449864498645,2.092648424370323,PIK3R3
GO_Biological_Process_2021,Bacterial invasion of epithelial cells,1/77,0.3810929668853574,0.5243406778422648,0,0,2.1181001283697047,2.0433564544006257,PIK3R3
GO_Biological_Process_2021,Colorectal cancer,1/86,0.414917331782972,0.5595626396684146,0,0,1.8929698708751796,1.66520012460197,PIK3R3
GO_Biological_Process_2021,Insulin secretion,1/86,0.414917331782972,0.5595626396684146,0,0,1.8929698708751796,1.66520012460197,KCNMB4
GO_Biological_Process_2021,Pathways in cancer,4/531,0.4189843510563196,0.5595626396684146,0,0,1.2238456672991778,1.0646499133130969,LAMA5;WNT2B;PIK3R3;LAMC1
GO_Biological_Process_2021,Gap junction,1/88,0.4221811707137241,0.5595626396684146,0,0,1.84926642369872,1.5946607957264258,ITPR1
GO_Biological_Process_2021,Ras signaling pathway,2/232,0.4226775906490668,0.5595626396684146,0,0,1.4002851033499644,1.2058493381358004,PIK3R3;RAPGEF5
GO_Biological_Process_2021,PD-L1 expression and PD-1 checkpoint pathway in cancer,1/89,0.4257794729758946,0.5595626396684146,0,0,1.828159645232816,1.560944379565104,PIK3R3
GO_Biological_Process_2021,Hypertrophic cardiomyopathy,1/90,0.4293555467698697,0.5595626396684146,0,0,1.8075271763953595,1.5282098625634657,PRKAG2
GO_Biological_Process_2021,Chemical carcinogenesis,2/239,0.4375337265137045,0.5595626396684146,0,0,1.3584422770975997,1.122890406227416,BCL6;PIK3R3
GO_Biological_Process_2021,Calcium signaling pathway,2/240,0.4396394107199178,0.5595626396684146,0,0,1.352665656426505,1.1116211898970467,ERBB4;ITPR1
GO_Biological_Process_2021,GnRH signaling pathway,1/93,0.4399517550367053,0.5595626396684146,0,0,1.7483209614704842,1.4355292179278711,ITPR1
GO_Biological_Process_2021,Salivary secretion,1/93,0.4399517550367053,0.5595626396684146,0,0,1.7483209614704842,1.4355292179278711,ITPR1
GO_Biological_Process_2021,Shigellosis,2/246,0.4521833970969831,0.5595626396684146,0,0,1.3190002687449611,1.0468475609200143,ITPR1;PIK3R3
GO_Biological_Process_2021,Fc gamma R-mediated phagocytosis,1/97,0.4537770031272727,0.5595626396684146,0,0,1.6751355013550135,1.323607284762619,PIK3R3
GO_Biological_Process_2021,Prostate cancer,1/97,0.4537770031272727,0.5595626396684146,0,0,1.6751355013550135,1.323607284762619,PIK3R3
GO_Biological_Process_2021,Aldosterone synthesis and secretion,1/98,0.4571800835620697,0.5595626396684146,0,0,1.657782247925572,1.2975095446652958,ITPR1
GO_Biological_Process_2021,Glycerophospholipid metabolism,1/98,0.4571800835620697,0.5595626396684146,0,0,1.657782247925572,1.2975095446652958,CHPT1
GO_Biological_Process_2021,mRNA surveillance pathway,1/98,0.4571800835620697,0.5595626396684146,0,0,1.657782247925572,1.2975095446652958,PPP2R3A
GO_Biological_Process_2021,AGE-RAGE signaling pathway in diabetic complications,1/100,0.4639232772068564,0.5595626396684146,0,0,1.6241274533957462,1.2473885010387038,PIK3R3
GO_Biological_Process_2021,Progesterone-mediated oocyte maturation,1/100,0.4639232772068564,0.5595626396684146,0,0,1.6241274533957462,1.2473885010387038,PIK3R3
GO_Biological_Process_2021,Endocytosis,2/252,0.4645687384491673,0.5595626396684146,0,0,1.286950819672131,0.9866353736999972,TSG101;RAB11FIP3
GO_Biological_Process_2021,Melanogenesis,1/101,0.4672636475581606,0.5595626396684146,0,0,1.6078048780487806,1.223317031899048,WNT2B
GO_Biological_Process_2021,Pancreatic secretion,1/102,0.470583370398377,0.5600808212103383,0,0,1.5918055220156162,1.199874573379242,ITPR1
GO_Biological_Process_2021,T cell receptor signaling pathway,1/104,0.4771613788957853,0.5610261060956506,0,0,1.560738811271608,1.1547914654966442,PIK3R3
GO_Biological_Process_2021,Toll-like receptor signaling pathway,1/104,0.4771613788957853,0.5610261060956506,0,0,1.560738811271608,1.1547914654966442,PIK3R3
GO_Biological_Process_2021,"Parathyroid hormone synthesis, secretion and action",1/106,0.4836583063672189,0.5652392255134968,0,0,1.5308555942702284,1.1119776819108949,ITPR1
GO_Biological_Process_2021,Serotonergic synapse,1/113,0.5057732439956629,0.587544966078794,0,0,1.4346689895470384,0.9779662830536217,ITPR1
GO_Biological_Process_2021,Leukocyte transendothelial migration,1/114,0.5088548536324593,0.5876062000279589,0,0,1.4219008561767033,0.9606255015023294,PIK3R3
GO_Biological_Process_2021,Thyroid hormone signaling pathway,1/121,0.5298989245357127,0.6082863394078597,0,0,1.3384823848238483,0.8500286683712083,PIK3R3
GO_Biological_Process_2021,MAPK signaling pathway,2/294,0.5464521479057983,0.6199656225508848,0,0,1.0994834942735234,0.6644272610151457,ERBB4;MAP3K5
GO_Biological_Process_2021,Osteoclast differentiation,1/127,0.547223130934848,0.6199656225508848,0,0,1.2743579816750548,0.7683086967291537,PIK3R3
GO_Biological_Process_2021,Oocyte meiosis,1/129,0.5528559417592942,0.6199656225508848,0,0,1.254319105691057,0.7433820199201372,ITPR1
GO_Biological_Process_2021,Relaxin signaling pathway,1/129,0.5528559417592942,0.6199656225508848,0,0,1.254319105691057,0.7433820199201372,PIK3R3
GO_Biological_Process_2021,Natural killer cell mediated cytotoxicity,1/131,0.5584192349873867,0.6226053539514541,0,0,1.2348968105065663,0.7195067998015446,PIK3R3
GO_Biological_Process_2021,Oxidative phosphorylation,1/133,0.5639138616726069,0.6251387952256328,0,0,1.2160630697216064,0.6966263100091936,PPA1
GO_Biological_Process_2021,Yersinia infection,1/137,0.5747004682453368,0.6334766524977008,0,0,1.1800573888091823,0.6536412204935567,PIK3R3
GO_Biological_Process_2021,Measles,1/139,0.579994099124176,0.6356997470626561,0,0,1.1628372805467184,0.6334408980085956,PIK3R3
GO_Biological_Process_2021,Herpes simplex virus 1 infection,3/498,0.5998560623856921,0.6535502616550529,0,0,0.970748810418232,0.4961162733195746,ZNF160;PIK3R3;CALR
GO_Biological_Process_2021,Phospholipase D signaling pathway,1/148,0.6030180249291467,0.6535502616550529,0,0,1.0911454012499309,0.5519102811025498,PIK3R3
GO_Biological_Process_2021,Adrenergic signaling in cardiomyocytes,1/150,0.6079619199616901,0.6552478470698215,0,0,1.0763900256452228,0.5356579944905504,PPP2R3A
GO_Biological_Process_2021,Necroptosis,1/159,0.6294643118954238,0.673350190514482,0,0,1.0146135638571576,0.4696505357556612,GLUD1
GO_Biological_Process_2021,Hepatitis B,1/162,0.6363685000271508,0.673350190514482,0,0,0.995556228854214,0.4499689963844095,PIK3R3
GO_Biological_Process_2021,JAK-STAT signaling pathway,1/162,0.6363685000271508,0.673350190514482,0,0,0.995556228854214,0.4499689963844095,PIK3R3
GO_Biological_Process_2021,Hippo signaling pathway,1/163,0.6386414178075499,0.673350190514482,0,0,0.9893606343470842,0.443641322846149,WNT2B
GO_Biological_Process_2021,Wnt signaling pathway,1/166,0.6453759573952627,0.67677262559287,0,0,0.9712244395171225,0.4253207940539602,WNT2B
GO_Biological_Process_2021,Influenza A,1/172,0.6584737697095122,0.6867952221701363,0,0,0.9368611229971948,0.3914492376315144,PIK3R3
GO_Biological_Process_2021,NOD-like receptor signaling pathway,1/181,0.6772259599418546,0.7009234722278812,0,0,0.8896115627822945,0.3467263692308421,ITPR1
GO_Biological_Process_2021,Axon guidance,1/182,0.6792454266950602,0.7009234722278812,0,0,0.8846516641962,0.3421591689603978,PIK3R3
GO_Biological_Process_2021,Neutrophil extracellular trap formation,1/189,0.693035035804481,0.7113692960109488,0,0,0.8514097906936516,0.3121904503146862,PIK3R3
GO_Biological_Process_2021,Chemokine signaling pathway,1/192,0.6987633129086323,0.7134741194961824,0,0,0.8379091644319585,0.3003428440778311,PIK3R3
GO_Biological_Process_2021,Pathogenic Escherichia coli infection,1/197,0.7080757379572221,0.7191973464068121,0,0,0.8163265306122449,0.2817993604032101,GAPDH
GO_Biological_Process_2021,Regulation of actin cytoskeleton,1/218,0.744168358364972,0.7519201120979405,0,0,0.7365404068787231,0.2176388382126561,PIK3R3
GO_Biological_Process_2021,Coronavirus disease,1/232,0.7657337377843045,0.7697012701044305,0,0,0.6914088621405694,0.1845513861940674,PIK3R3
GO_Biological_Process_2021,Salmonella infection,1/249,0.7895090241277948,0.7895090241277948,0,0,0.6434565958562811,0.1520771154528706,GAPDH
